Protein and DNA nanoparticulate multiantigenic
vaccines against H. pylori: in vivo evaluation
Lara Figueiredo
1,2
, Cecília C.R. Calado
2
, António J. Almeida
1
, Lídia M.D. Gonçalves
1
1
Faculdade de Farmácia, Universidade de Lisboa iMed.UL
Lisboa, Portugal; (lgoncalves@ff.ul.pt / aalmeida@ff.ul.pt)
2
Faculdade de Engenharia da Universidade Católica Portuguesa,
Rio de Mouro, Portugal (c.calado@fe.lisboa.ucp.pt)
Abstract—Immunisation against H. pylori is an attractive option
for antibiotic resistance and reinfection situations. Strain genetic
heterogeneity, and low immunogenicity of protein antigens and
DNA alone are nonetheless obstacles to this approach. We
developed multigenic H. pylori DNA-nanoparticle and protein-
nanoparticle vaccines based on pathogenic relevance. Six
antigens were chosen for the vaccine construction: CagA, VacA,
HpaA, UreB, HomB and GroEL. Different combinations of
CS/DS and CS/Alg /TPP nanoparticles with DNA and chimeric
proteins were produced as vaccine systems. Immune responses
were evaluated after i.m. and oral immunisation of BALB/c mice.
Oral vaccination successfully stimulated mucosal immunity while
i.m. immunisation efficiently elicited a more equilibrated
cellular/humoral immune response.
Index Terms—nanoparticles; chitosan; vaccine; Helicobacter
pylori.
Helicobacter pylori
et al
,
et al
H. pylori
et al.
et al
A. Protein and DNA chitosan nanoparticle characterization
B. In vivo sudies
A. Materials
B. Animals
in vivo
Authorized licensed use limited to: b-on: Instituto Politecnico de Lisboa. Downloaded on July 30,2020 at 14:59:03 UTC from IEEE Xplore. Restrictions apply.